- Home
- BFST vs IART Comparison
BFST vs IART Comparison
Compare BFST & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFST | IART |
|---|---|---|
| Founded | 2006 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 951.9M |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BFST | IART |
|---|---|---|
| Price | $32.36 | $13.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | ★ $37.05 | $15.67 |
| AVG Volume (30 Days) | 160.1K | ★ 1.2M |
| Earning Date | 10-26-2026 | 10-21-2026 |
| Dividend Yield | ★ 1.86% | N/A |
| EPS Growth | ★ 23.45 | N/A |
| EPS | ★ 2.08 | 0.19 |
| Revenue | ★ $10,704,000.00 | N/A |
| Revenue This Year | $14.30 | $0.55 |
| Revenue Next Year | $6.61 | $1.86 |
| P/E Ratio | ★ $15.86 | $78.00 |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $24.19 | $8.70 |
| 52 Week High | $33.60 | $20.49 |
Technical Indicators
Market Signals| Indicator | BFST | IART |
|---|---|---|
| Relative Strength Index (RSI) | 58.38 | 49.13 |
| Support Level | $30.86 | $11.96 |
| Resistance Level | N/A | $14.28 |
| Average True Range (ATR) | 0.86 | 0.80 |
| MACD | 0.08 | 0.29 |
| Stochastic Oscillator | 57.69 | 53.26 |
Price Performance
Historical ComparisonAbout BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.